Zosano Pharma

Zosano Pharma Corporation is a clinical-stage biopharmaceutical company focused on providing systemic administration of therapeutics to patients using a proprietary Adhesive Dermally-Applied Microneedle technology. The lead clinical asset has completed the pivotal efficacy trial and is filing for approval in 2020.

• Chief Executive Officer - Westwood & Wilshire partnered with Zosano to identify a succession CEO to lead the build out of the commercial infrastructure and launch of the company’s lead asset